Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
HRMY earnings call for the period ending December 31, 2023.
Source: yahoo.com
Page 14 - Alkermes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alkermes Today - Breaking & Trending Today
Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
HRMY earnings call for the period ending December 31, 2023.
Source: fool.com
Alkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Alkermes plc (NASDAQ:ALKS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight research firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]
Source: dailypolitical.com
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
Catalyst-rich 2024 with multiple clinical data readouts and updates expected for pipeline and discovery programs Phase 2/3 Duravelo-2 registrational trial for BT8009 in metastatic urothelial cancer...
Source: marketscreener.com
Modified Release Neurology Therapeutics Report 2024 - Neurology Therapeutics Advance with Modified R
DUBLIN--(BUSINESS WIRE)--The "Modified Release Neurology Therapeutics" report has been added to ResearchAndMarkets.com's offering.Large pharmaceutical and biotechnology companies are increasingly pursuing in-licensing to offset lower than expected drug development productivity and surging research costs. Data mining...
Source: pharmiweb.com